SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041151
Filing Date
2023-11-14
Accepted
2023-11-14 16:24:29
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2067562
2 ex10-1.htm EX-10.1 80054
3 ex10-2.htm EX-10.2 243141
4 ex10-3.htm EX-10.3 57260
5 ex10-4.htm EX-10.4 52885
6 ex10-5.htm EX-10.5 83722
7 ex10-6.htm EX-10.6 80935
8 ex10-7.htm EX-10.7 23250
9 ex31-1.htm EX-31.1 11435
10 ex31-2.htm EX-31.2 11374
11 ex32-1.htm EX-32.1 7830
12 ex10-1_001.jpg GRAPHIC 3665
  Complete submission text file 0001493152-23-041151.txt   8504850

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE gnlx-20230930.xsd EX-101.SCH 54973
14 XBRL CALCULATION FILE gnlx-20230930_cal.xml EX-101.CAL 50342
15 XBRL DEFINITION FILE gnlx-20230930_def.xml EX-101.DEF 275928
16 XBRL LABEL FILE gnlx-20230930_lab.xml EX-101.LAB 472702
17 XBRL PRESENTATION FILE gnlx-20230930_pre.xml EX-101.PRE 371500
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 982466
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41599 | Film No.: 231406799
SIC: 2834 Pharmaceutical Preparations